In Treatment of Tuberculosis (TB) Tuberculosis is an infectious disease that mainly affects the lungs but can affect other parts of the body as well. Zibutol INH 300mg/800mg Tablet helps treat tuberculosis by stopping the growth of bacteria causing infection. Your symptoms might improve after using Zibutol INH 300mg/800mg Tablet. However, make sure to complete the full course of treatment. This will ensure that the infection is completely cured and prevent it from returning.
Consuming alcohol while taking Zibutol INH 300mg/800mg Tablet may cause symptoms such as flushing, increased heart beat, nausea, thirst, chest pain and low blood pressure (Disulfiram reaction).
Zibutol INH 300mg/800mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Zibutol INH 300mg/800mg Tablet is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Zibutol INH 300mg/800mg Tablet may cause side effects which could affect your ability to drive. Zibutol INH 300mg/800mg Tablet occasionally causes sight problems and tingling or numbness in hand or feet. After taking this medicine you should not drive until you know how it affects you.
Zibutol INH 300mg/800mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Zibutol INH 300mg/800mg Tablet may be needed. Please consult your doctor. Kidney function tests are advisable before the start of this medicine.
Zibutol INH 300mg/800mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Zibutol INH 300mg/800mg Tablet may be needed. Please consult your doctor.
If you miss a dose of Zibutol INH 300mg/800mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Shreya Life Sciences Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Themis Medicare Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Pan Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Finecure Pharmaceuticals Ltd. || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Marc Laboratories Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Mediwin Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Wockhardt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Macleods Pharmaceuticals Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Bonsai Pharma || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Lupin Ltd || ₹14.5/tablet (25% cheaper)